1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pancreatic Cancer: Disease and Pipeline Analysis

Pancreatic Cancer: Disease and Pipeline Analysis

  • March 2013
  • -
  • Industry Standard Research
  • -
  • 67 pages

Summary

Table of Contents

The pancreas is the 10th most common site of new cancers but is the 4th leading cause of cancer death, largely due the difficulties associated with diagnosing the disease in its early stages. As a consequence, over 80% of patients present with regional spread or distant disease at the time of diagnosis (Stage III or Stage IV) and are unsuitable for surgical resection. Survival rates from the disease are among the lowest for any type of cancer with a median survival time of 4-6 months from diagnosis, a 1-year survival rate of 26% and a 5-year survival rate of only 6%. Following curative resection, median survival time increases to between 12 and 19 months.

In a market with few available therapies that exhibit limited effectiveness and a disease class still classified as “rare”, poor survival rates and lack of viable treatment options remain compelling reasons to develop new “Orphan” therapies to address this large unmet need.

What you will learn in this report:

• Information on over sixty potential new therapies in active development
• Incidence rate of pancreatic cancer for each of the major and emerging global markets
• Drug approval dynamics by country
• Trial and Recruitment environment
• Regulatory environment
• Competitive product landscape
• Pricing and reimbursement environment

How you can use this report:

• Optimize your product’s global development and commercial strategies
• Benchmark trial length and number of patients (by Phase)
• Identify drug candidates for partnering strategies
• Evaluate your pipeline against products currently in development
• Identify the most effectives market entry strategies

Valuable for:

1. Brand Managers
2. Medical Directors
3. Portfolio Managers
4. Executive Suite

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Pancreatic Cancer - Market Insights, Epidemiology and Market  Forecast-2023

Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2014 - 2025

Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • February 2017
  • by Grand View Research

The global pancreatic cancer treatment market is expected to reach USD 4.2 billion in 2025, according to a new report by Grand View Research, Inc. Increasing tobacco consumption, smoking, obesity, and ...

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2017 - 2022)

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global pancreatic cancer market is expected to grow modestly from USD 1,730 million in 2015, growing at a CAGR of 10-17%. Globally, pancreatic cancer is the 12th most common cancer in men and 11th ...


ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.